检索结果 - Li, Runzi
- Showing 1 - 5 results of 5
-
1
-
2
-
3
-
4
Safety and efficacy of SHR4640 combined with febuxostat for primary hyperuricemia: a multicenter, randomized, double-blind, phase II study 由 Tang, Honghu, Cui, Beibei, Chen, Yiyu, Chen, Lin, Wang, Zhihong, Zhang, Ning, Yang, Yanlan, Wang, Xiaodong, Xie, Xiangliang, Sun, Lingyun, Dang, Wantai, Wang, Xianyang, Li, Runzi, Zou, Jianjun, Zhao, Yi, Liu, Yi
出版 2022Text -
5
A multicenter, randomized phase III trial of hetrombopag: a novel thrombopoietin receptor agonist for the treatment of immune thrombocytopenia 由 Mei, Heng, Liu, Xiaofan, Li, Yan, Zhou, Hu, Feng, Ying, Gao, Guangxun, Cheng, Peng, Huang, Ruibin, Yang, Linhua, Hu, Jianda, Hou, Ming, Yao, Yazhou, Liu, Li, Wang, Yi, Wu, Depei, Zhang, Liansheng, Zheng, Changcheng, Shen, Xuliang, Hu, Qi, Liu, Jing, Jin, Jie, Luo, Jianmin, Zeng, Yun, Gao, Sujun, Zhang, Xiaohui, Zhou, Xin, Shi, Qingzhi, Xia, Ruixiang, Xie, Xiaobao, Jiang, Zhongxing, Gao, Li, Bai, Yuansong, Li, Yan, Xiong, Junye, Li, Runzi, Zou, Jianjun, Niu, Ting, Yang, Renchi, Hu, Yu
出版 2021Text